Literature DB >> 9203080

Autoradiographic characterization of [3H]inositol (1,4,5) trisphosphate and [3H]inositol (1,3,4,5) tetrakisphosphate binding sites in human brain.

T Kurumatani1, R F Cowburn, N Bogdanovic, B Winblad, J Fastbom.   

Abstract

Autoradiographic techniques were used to investigate the characteristics of tritiated inositol(1,4,5)trisphosphate ([3H]IP3) and inositol (1,3,4,5) tetrakisphosphate ([3H]IP4) binding to human brain. In brain sections [3H]IP3 exhibited a two-site binding with KD values of 87 nM and 9.3 microM respectively for the higher and lower affinity sites. [3H]IP4 also bound to two sites with KD values of 43 nM and 1.4 microM, respectively. With the conditions fixed in this study, [3H]IP3 and [3H]IP4 autoradiography in the cortex, caudate, hippocampus and cerebellum were performed. The most prominent [3H]IP3 binding among these regions was found in the cerebellum, particularly in the molecular layer. Within the hippocampus, the subiculum and the CA1 region showed much more prominent binding than the other subfields. [3H]IP4, binding was fairly homogeneous in the regions studied, with the exception of a slightly higher binding in the molecular layer of the cerebellum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203080     DOI: 10.1007/BF01273179

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  23 in total

1.  Purification of a high-affinity inositol 1,3,4,5-tetrakisphosphate receptor from brain.

Authors:  F Donié; G Reiser
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

2.  Characteristics of [3H]inositol(1,3,4,5)tetrakisphosphate recognition sites in human cerebellar membranes.

Authors:  A Garlind; R F Cowburn; C J Fowler
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  The inositol 1,4,5-trisphosphate receptor binding sites of platelet membranes. pH-dependency, inhibition by polymeric sulphates, and the possible presence of arginine at the binding site.

Authors:  F O'Rourke; M B Feinstein
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

4.  Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.

Authors:  R A Challiss; E R Chilvers; A L Willcocks; S R Nahorski
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

5.  [3H]inositol 1,4,5-triphosphate binding in human cerebral cortex.

Authors:  L T Young; P P Li; S J Kish; A S Chiu; J J Warsh
Journal:  Neurosci Lett       Date:  1988-05-03       Impact factor: 3.046

6.  Inositol 1,3,4,5-tetrakisphosphate binding sites in neuronal and non-neuronal tissues. Properties, comparisons and potential physiological significance.

Authors:  P J Cullen; R F Irvine
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Autoradiographic analysis of second messenger and neurotransmitter system receptors in the gerbil hippocampus following transient forebrain ischemia.

Authors:  H Hara; H Onodera; H Kato; T Araki; K Kogure
Journal:  Brain Res       Date:  1991-04-05       Impact factor: 3.252

8.  Regional tritium quenching in quantitative autoradiography of the central nervous system.

Authors:  W A Geary; G F Wooten
Journal:  Brain Res       Date:  1985-06-17       Impact factor: 3.252

9.  Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate.

Authors:  H Streb; R F Irvine; M J Berridge; I Schulz
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

10.  Development of a novel, Ins(1,4,5)P3-specific binding assay. Its use to determine the intracellular concentration of Ins(1,4,5)P3 in unstimulated and vasopressin-stimulated rat hepatocytes.

Authors:  S Palmer; K T Hughes; D Y Lee; M J Wakelam
Journal:  Cell Signal       Date:  1989       Impact factor: 4.315

View more
  1 in total

1.  Altered calcium signaling following traumatic brain injury.

Authors:  John T Weber
Journal:  Front Pharmacol       Date:  2012-04-12       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.